PMA Approval Preempts State Tort Claims Against Manufacturer – 3rd Circuit
This article was originally published in The Gray Sheet
Executive Summary
The U.S. Third Circuit appellate court's ruling in Horn v. Thoratec lends weight to recent FDA amicus curiae briefs, which argue agency premarket review of devices preempts state tort claims
You may also be interested in...
Troy Advances Case For Preemption; Verdict On Liability Reform Still Pending
Product liability reform measures likely will have to include an alternative compensation program for injured consumers, former FDA Chief Counsel Daniel Troy said Jan. 26
Troy Advances Case For Preemption; Verdict On Liability Reform Still Pending
Product liability reform measures likely will have to include an alternative compensation program for injured consumers, former FDA Chief Counsel Daniel Troy said Jan. 26
Meet Masoudi: Deputy Counsel Brings Antitrust Experience To FDA
FDA Deputy Chief Counsel Gerald Masoudi can be expected to reinforce the agency's aggressive stance toward product liability suits that encroach on its regulatory authority